Justin Hays is the Chief Executive Officer of Landcent Europe. With over a decade of experience in pharmaceuticals and diagnostics, he has held senior commercial roles at Horizon Therapeutics and previously served as Vice President of Commercial at Landcent.

Arun Prabhu is the Founder and Executive Chairman of Landcent Europe. He has guided the company from its early-stage research and development into a globally engaged enterprise with a growing pipeline and strong strategic partnerships. With a background in technical textiles and supply chain management, Arun now leads Landcent’s Prevention (Vector Control) business, advancing innovation in malaria prevention across endemic regions.

Sasikanth has more than 30 years of experience in multiple facets of finance. Prior to joining Landcent, he served as Vice President of Finance and Accounts at SP Mani and Mohan Dairy India Pvt. Ltd., eventually being promoted to COO at the same company.

Dr. Peter Atadja is the Chief Scientific Officer at Landcent and a Professor of Biomedical Sciences at the University of Health and Allied Sciences in Ghana. He has 25 years of pharmaceutical industry experience, including serving on the founding leadership team of Novartis' major R&D centre in Shanghai, where he led the discovery and clinical translation of multiple first- and best-in-class drug candidates. He also served on the WHO/TDR/ANDI Scientific and Technology Committee to strengthen diagnostic and drug development capacity in Africa. Most recently, he was co-founder and Chief Scientific Officer of K-36 Therapeutics, a clinical-stage biopharmaceutical company in Cambridge, Massachusetts.

With a background in public health and a PhD in malaria interventions using innovative technologies, Marlize has helped country programs adopt and expand these tools. She has collaborated with local communities, researchers, industry, and regional governments in Africa to deliver disease prevention solutions. She served as Assistant Director at South Africa's Ministry of Health and as a consultant for WHO and malaria-endemic programs. Marlize has led research and managed initiatives on malaria, HIV, and leishmaniasis in Africa, the Philippines, and India. She has worked with institutions like Colorado State University, Liverpool School of Tropical Medicine, and IVCC.

Andrea is a lawyer with 20+ years’ experience in private practice, in-house counsel, and supervisory board roles. Before Landcent, she worked at Clifford Chance Amsterdam and Randstad, and holds several non-executive directorships. Qualified in South Africa and the UK, her expertise spans corporate governance, M&A, risk, and compliance. At Landcent, she oversees all legal matters, including governance, compliance, policy, joint ventures, and strategic transactions, offering pragmatic legal solutions and board-level insight.

Erik has over 20 years of experience in pharmaceuticals and diagnostics. He served in various leadership roles within JNJ and served as Head of Global Feasibility and Head of Vendor management for Vaccine Immunological assays. His expertise includes clinical research, contract management, diagnostics, and partnership management.

With over six years of experience in healthcare marketing and communications, Elina brings strategic insight and hands-on expertise to Landcent, where she leads all corporate marketing and communication efforts. She holds a master’s degree in strategic business development and a bachelor’s in sales and visual marketing.